Retrieve available abstracts of 34 articles: HTML format
Single Articles
April 2025
JIANG H No-touch vein harvesting in coronary artery bypass surgery.
BMJ. 2025;389:r728. PubMed
TIAN M, Wang X, Feng W, Wang H, et al No-touch versus conventional vein in coronary artery bypass grafting: three year
follow-up of multicentre randomised PATENCY trial.
BMJ. 2025;389:e082883. PubMedAbstract available
March 2025
GAO C, Zhu B, Ouyang F, Wen S, et al Stepwise dual antiplatelet therapy de-escalation in patients after drug coated
balloon angioplasty (REC-CAGEFREE II): multicentre, randomised, open label,
assessor blind, non-inferiority trial.
BMJ. 2025;388:e082945. PubMedAbstract available
BELLOLIO F, Gottlieb M, Body R, Than MP, et al Evaluating patients with chest pain in the emergency department.
BMJ. 2025;388:r136. PubMedAbstract available
HAN J, Zhai W, Wu Z, Zhang Z, et al Care guided by tissue oxygenation and haemodynamic monitoring in off-pump
coronary artery bypass grafting (Bottomline-CS): assessor blind, single centre,
randomised controlled trial.
BMJ. 2025;388:e082104. PubMedAbstract available
February 2025
YONIS H, Lokkegaard E, Kragholm K, Granger CB, et al Stroke and myocardial infarction with contemporary hormonal contraception:
real-world, nationwide, prospective cohort study.
BMJ. 2025;388:e082801. PubMedAbstract available
WISE J Exercise referral rates for patients with risk of cardiovascular disease vary
widely across England, study reports.
BMJ. 2025;388:r287. PubMed
January 2025
HU W, Tao C, Wang L, Chen Z, et al Intra-arterial tenecteplase after successful endovascular recanalisation in
patients with acute posterior circulation arterial occlusion (ATTENTION-IA):
multicentre randomised controlled trial.
BMJ. 2025;388:e080489. PubMedAbstract available
November 2024
JOHANSSON T, Karlsson T, Bliuc D, Schmitz D, et al Contemporary menopausal hormone therapy and risk of cardiovascular disease:
Swedish nationwide register based emulated target trial.
BMJ. 2024;387:e078784. PubMedAbstract available
MAHASE E Cardiovascular disease: Just one in 12 eligible people had health check last
year, watchdog finds.
BMJ. 2024;387:q2518. PubMed
October 2024
Trends in cardiovascular disease incidence among 22 million people in the UK over
20 years: population based study.
BMJ. 2024;387:q2381. PubMed
LU J, Xu Y, Bi Y, Wang T, et al Reducing inequity through tackling social determinants of cardiovascular diseases
in China.
BMJ. 2024;387:e079197. PubMed
September 2024
INOUE K, Athey S, Baicker K, Tsugawa Y, et al Heterogeneous effects of Medicaid coverage on cardiovascular risk factors:
secondary analysis of randomized controlled trial.
BMJ. 2024;386:e079377. PubMedAbstract available
YANG C, Tebbutt SJ Effects of Medicaid coverage on cardiovascular health outcomes.
BMJ. 2024;386:q1807. PubMedAbstract available
August 2024
MENG R, Wang W, Huang T, Zhan S, et al Tackling social and behavioural risk factors for cardiovascular diseases in
Chinese women.
BMJ. 2024;386:e078638. PubMed
MAHASE E Incidence of cardiovascular events was lower after covid-19 vaccination, study
finds.
BMJ. 2024;386:q1732. PubMed
July 2024
IACOBUCCI G Semaglutide: UK regulator approves drug for prevention of cardiovascular events.
BMJ. 2024;386:q1660. PubMed
June 2024
Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered
data from Minnesota Coronary Experiment (1968-73).
BMJ. 2024;385:q1450. PubMed
CONRAD N, Molenberghs G, Verbeke G, Zaccardi F, et al Trends in cardiovascular disease incidence among 22 million people in the UK over
20 years: population based study.
BMJ. 2024;385:e078523. PubMedAbstract available
ZHU Y, Zhang W, Dimagli A, Han L, et al Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of
randomised DACAB trial.
BMJ. 2024;385:e075707. PubMedAbstract available
SANDNER S Dual antiplatelet therapy after coronary artery bypass surgery.
BMJ. 2024;385:q1083. PubMed
Effect of combination treatment with glucagon-like peptide-1 receptor agonists
and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and
serious renal events: population based cohort study.
BMJ. 2024;385:q1237. PubMed
May 2024
DYER C Former cardiovascular surgery lead is charged with 14 counts of sexual assault.
BMJ. 2024;385:q1188. PubMed
Cardiovascular toxicity of immune therapies for cancer.
BMJ. 2024;385:q1197. PubMed
Effect of combination treatment with glucagon-like peptide-1 receptor agonists
and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and
serious renal events: population based cohort study.
BMJ. 2024;385:q1094. PubMed
PALASKAS NL, Ali HJ, Koutroumpakis E, Ganatra S, et al Cardiovascular toxicity of immune therapies for cancer.
BMJ. 2024;385:e075859. PubMedAbstract available
LI Z, Min XW, He PG, Zhang CH, et al Chest pain with diffuse ST segment elevation.
BMJ. 2024;385:e078403. PubMed
April 2024
SIMMS-WILLIAMS N, Treves N, Yin H, Lu S, et al Effect of combination treatment with glucagon-like peptide-1 receptor agonists
and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and
serious renal events: population based cohort study.
BMJ. 2024;385:e078242. PubMedAbstract available
MOK PLH, Carr MJ, Guthrie B, Morales DR, et al Multiple adverse outcomes associated with antipsychotic use in people with
dementia: population based matched cohort study.
BMJ. 2024;385:e076268. PubMedAbstract available
VINTER N, Cordsen P, Johnsen SP, Staerk L, et al Temporal trends in lifetime risks of atrial fibrillation and its complications
between 2000 and 2022: Danish, nationwide, population based cohort study.
BMJ. 2024;385:e077209. PubMedAbstract available
March 2024
WONDERLING D, Mariani A, Samarasekera EJ, Wilkinson C, et al Secondary prevention of cardiovascular disease, including cholesterol targets:
summary of updated NICE guidance.
BMJ. 2024;384:q637. PubMed
SAUL H, Deeney B, Swaithes L, Hounkpatin H, et al Even short periods of diabetes remission are linked to lower risk of heart attack
and stroke.
BMJ. 2024;384:q516. PubMedAbstract available
TANNE JH Wegovy: FDA approves weight loss drug to cut cardiovascular risk.
BMJ. 2024;384:q642. PubMed
February 2024
Exposure-response associations between chronic exposure to fine particulate
matter and risks of hospital admission for major cardiovascular diseases:
population based cohort study.
BMJ. 2024;384:q517. PubMed